Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Entire Regional Nodal Irradiation vs. Level I-II Axillary Irradiation in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macro-metastases (RELAX)：A Prospective, Multicenter, Randomized, Phase 3 Clinical Trial

NCT07469267 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT07469267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07469267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Entire Regional Nodal Irradiation vs. Level I-II Axillary Irradiation in Clinically Node-negative Breast Cancer Patients With 1-2 Sentinel Node Macro-metastases (RELAX)：A Prospective, Multicenter, Randomized, Phase 3 Clinical Trial
Lead sponsor
Fudan University
Phase
Not applicable
Overall status
Recruiting
Start date
October 24, 2025
Completion date
December 31, 2035
Enrollment
1,608 (estimated)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, radiotherapy